BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 6, 2014
View Archived Issues
Potent c-Ros-1 inhibitors discovered at Janssen and NovAliX
Read More
Antiangiogenic and antitumor activity described for alpha-tocopherol analogue
Read More
Gene identified as a possible novel biomarker for frontotemporal lobar degeneration
Read More
ElexoPharm and Merck & Co. report CYP11B2 inhibitors for heart failure and hypertension
Read More
U.S. institutions divulge novel GSK-3 inhibitors
Read More
Loxo Oncology initiates phase I study of Trk inhibitor for cancer
Read More
Covagen initiates first clinical trial of FynomAb bispecific inhibitor
Read More
Addition of VX-661 to Kalydeco improves lung function in phase II trial in CF
Read More
Promising preclinical results for a novel, live-attenuated plague vaccine
Read More
Ruthigen submits IND for anti-infective surgical lavage
Read More
Phase III ovarian cancer trial of vintafolide stopped due to lack of efficacy
Read More
Camicinal proves well tolerated in diabetic patients with gastroparesis
Read More
Bristol-Myers Squibb describes novel FXIa inhibitors
Read More
New macrocyclic ketoamides disclosed by Roche
Read More
Bristol-Myers Squibb updates pipeline progress of first quarter 2014
Read More
NIH gives grant to Scripps Research Institute to develop diagnostics
Read More
Cellectar Biosciences' glioma diagnostic obtains FDA orphan drug designation
Read More
diaDexus completes validation study for PLAC Test for Lp-PLA2 Activity
Read More
Advaxis' immunotherapy product to enter clinic for pediatric bone cancer
Read More
ADDF raises funding for trial investigating rasagiline for Alzheimer's disease
Read More
Pierre Fabre obtains European approval for Hemangiol
Read More
World Asthma Day: Disease control through discovery of new therapeutic targets and models
Read More
Acorda receives complete response letter from FDA for Plumiaz
Read More
FDA approves Epanova for hypertriglyceridemia
Read More
FDA approves IND for Kinex's Oratecan
Read More
Alexion achieves regular approval for Soliris in aHUS
Read More